REGENECARE HA (Lidocaine HCL 2%) Topical Anesthetic Hydrogel, Net Wt. 3 oz. (85 g), Manufactured For: MPM Medical Mesquite, TX 75149. NDC 66977-107-03
Published December 9, 2020 · Recall initiated: November 17, 2020
Summary
FDA records drug Class I recall D-0118-2021, published December 9, 2020 and initiated November 17, 2020. Recalling firm: MPM Medical LLC; Status: Terminated; Reported quantity: 7,637 tubes; Lot: Lot: 41262 Exp. 01/21. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.
What to do
Voluntary: Firm initiated · Letter
Get an email if REGENECARE HA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- REGENECARE HA
- Manufacturer
- MPM Medical LLC
- Distributor
- Distributed Nationwide in the USA
- UPC
- 0366977112055
- Lot
- Lot: 41262 Exp. 01/21
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: MarlexDecember 9, 2020
- FDAClobetasol Propionate Ointment USP 0.05%, Net Wt. 50 grams, Rx Only, Teligent Pharma. Inc. Buena, NJ 08310 NDCDecember 9, 2020
- FDAAripiprazole Tablets, USP, 15 mg, 30 tablets per unit dose carton, Rx Only, Manufactured by: Apotex, Inc,December 9, 2020
- FDAAnagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., BaskingDecember 9, 2020
- FDACVS Health Hydrating Healing Ointment (Petrolatum 41%), Net Wt 3 OZ (85g), Distributed by CVS Pharmacy, Inc.December 9, 2020
- FDATizanidine Tablets, USP 4mg, Rx Only, 150 Tablets per Bottle, Manufactured by Alkem Laboratories Ltd, Mumbai -December 9, 2020
Questions about this recall
Was REGENECARE HA (Lidocaine HCL 2%) Topical Anesthetic Hydrogel, Net Wt. 3 oz. (85 g), Manufactured For: MPM Medical Mesquite, TX 75149. NDC 66977-107-03 recalled?
Yes. FDA published recall D-0118-2021 on December 9, 2020. Reported hazard: Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: REGENECARE HA. UPC: 0366977112055.